---
title: "Hn.F&A.Co.,Ltd. released its performance for the first half of the year, with a net profit attributable to the parent company of 53.4774 million yuan, a year-on-year decrease of 45.61%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255176583.md"
description: "Hn.F&A.Co.,Ltd. released its semi-annual report for 2025. During the reporting period, the company's operating revenue was 517 million yuan, a year-on-year decrease of 14.65%; the net profit attributable to the parent company was 53.4774 million yuan, a year-on-year decrease of 45.61%; the net profit after deducting non-recurring gains and losses was 49.0031 million yuan, a year-on-year decrease of 45.66%; the basic earnings per share were 0.0384 yuan"
datetime: "2025-08-29T10:31:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255176583.md)
  - [en](https://longbridge.com/en/news/255176583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255176583.md)
---

# Hn.F&A.Co.,Ltd. released its performance for the first half of the year, with a net profit attributable to the parent company of 53.4774 million yuan, a year-on-year decrease of 45.61%

According to the Zhitong Finance APP, Hn.F&A.Co.,Ltd. (002277.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 517 million yuan, a year-on-year decrease of 14.65%. The net profit attributable to shareholders of the listed company was 53.4774 million yuan, a year-on-year decrease of 45.61%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 49.0031 million yuan, a year-on-year decrease of 45.66%. The basic earnings per share were 0.0384 yuan

### Related Stocks

- [002277.CN](https://longbridge.com/en/quote/002277.CN.md)

## Related News & Research

- [08:42 ETHealthWorX Calls for a New Healthcare Operating Model as Coverage Fails to Become Care](https://longbridge.com/en/news/295667366.md)
- [AlzeCure inks NeuroRestore Alzheimer’s licensing deal with QuantumCell for USD 12 million upfront](https://longbridge.com/en/news/295632889.md)
- [Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States](https://longbridge.com/en/news/295428346.md)
- [Alaska Energy Metals plans 8-hole, 2,125-meter drill program at McBride prospect in Quebec](https://longbridge.com/en/news/295396039.md)
- [ISS commences the second tranche of its share buyback programme including the announced increase by DKK 600 million](https://longbridge.com/en/news/295488152.md)